Organogenesis Holdings Inc.

ORGO· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences

$2.34-1.27%

2026-08-03

Financials

Valuation Metrics

Organogenesis Holdings Inc.'s Market Cap is $301M. At end of 2025 it was $657M. Ranked #2950 of 3,111 in US market (top 95%), #1321 of 1,445 on NASDAQ (top 91%), #242 of 269 in Pharmaceuticals, Biotechnology & Life Sciences (top 90%) by Market Cap.

Investment Metrics(as of 2026-08-03)

Metric	Value	Rank
Size
Market Cap	$301M	US#2,950/3,111 Sec#242/269
Revenue	$514M	US#2,340/3,111 Sec#81/269
Net Income	$-284000.00	US—/3,111 Sec—/269
Total Assets	$520M	US#2,732/3,111 Sec#152/269
Net Assets	$381M	US#2,431/3,111 Sec#142/269
Value
P/B	0.79x	US#218/3,111 Sec#9/269
P/S	0.59x	US#347/3,111 Sec#5/269
EV/EBITDA	7.50x	US#435/3,111 Sec#15/269
FCF Yield	5.67%	US#1,179/3,111 Sec#42/269
Profitability
ROE	-0.07%	US#2,161/3,111 Sec#75/269
ROA	-0.05%	US#2,221/3,111 Sec#76/269
Op. Margin	2.14%	US#2,307/3,111 Sec#82/269
Revenue Growth	-57.06%	US#2,895/3,111 Sec#164/269
Earnings Growth	4201.05%	US#9/3,111 Sec#2/269
Financial Health
Debt Ratio	36.36%	US#417/3,111 Sec#119/269
Total Debt	$71M	US#2,505/3,111 Sec#141/269
FCF	$17M	US#2,167/3,111 Sec#76/269
Cash	$92M	US#2,275/3,111 Sec#184/269
Current Ratio	3.53x	US#661/3,111 Sec#182/269
Net Debt/EBITDA	-0.57x	US#428/3,111 Sec#26/269
Performance
1Y Return	-48.12%	US#2,947/3,111 Sec#242/269
1M Return	-0.85%	US#1,885/3,111 Sec#126/269
From 52W High	-66.95%	US#2,976/3,111 Sec#250/269
1Y MDD	-65.75%	US#2,848/3,111 Sec#237/269
Trading
Volume	758,944 shares	US#1,375/3,111 Sec#133/269
Trading Value	$2M	US#2,848/3,111 Sec#235/269
Per Share
EPS	$0.29	US#1,943/3,111 Sec#68/269
BPS	$3.42	US#2,384/3,111 Sec#156/269